IBRX

IBRX Net Receivables

$53.47MQuarterly · USD

Period ending:

IBRX FY Net ReceivablesUSD
IBRX FY Net Receivables2013-12-31: $380.00K2014-12-31: $145.00K2015-12-31: $1.77M2016-12-31: $0.002017-12-31: $1.26M2018-12-31: $12.17M2019-12-31: $303.00K2020-12-31: $2.00M2021-12-31: $1.33M2022-12-31: $1.89M2023-12-31: $3.17M2024-12-31: $2.65M2025-12-31: $42.62M$42.62M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IBRX net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Immunitybio Inc Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
42,617,000
2,653,000
3,168,000
1,890,000
1,333,000
2,003,000
303,000
12,168,000
1,258,000
0
1,774,000
145,000
380,000

Compare net receivables

All IBRX financial metrics · IBRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.